Built to endure: Prince Korah on end-to-end medicine delivery

“My role is to ensure that every product we develop meets the highest standards of quality, safety, efficacy, and compliance.”

Robustness is not a box to check—it’s the foundation of every decision. As a Senior Director in analytical due diligence in Ipsen’s drug product development team, Prince Korah focuses on driving the pharmaceutical development strategy by overseeing the end-to-end life cycle of drug products—from early development through manufacturing and clinical delivery—ensuring each stage meets rigorous quality, regulatory, and performance standards. His goal is clear: design for stability, simplify where possible, and always center the science.

In development of medicines, the pressure is real. Timelines are short, stakes are high, and there is little room for error. Prince responds by defining and controlling the key variables that influence stability. “We design with the end in mind,” he says. “The patient, the dose, the shelf life—it all has to hold together.”

That mindset requires discipline. Every formulation choice ties back to rigorous quality and regulatory performance standards. Platform strategies help, but only if they serve the product. “If you can build a platform approach, you gain consistency,” he explains. “It allows you to apply lessons across programs.” But he cautions against rigid thinking. “Even within a platform, we ask: can we make it simpler, safer, and more robust?”

Process design is where his work becomes most visible. He collaborates cross-functionally across chemists, formulators, analytics, manufacturing experts, quality, and regulatory experts to define how the drug product is produced, filled, and finished. It is not just about technical accuracy—it is about reliability. If a process fails in production, speed means nothing. “You have to build it to endure,” he says.

Prince looks ahead to a future shaped by continuous manufacturing and AI-driven control systems. He sees the shift toward personalized medicine as a scientific challenge worth solving. “It will change everything we know about production,” he says. “We need to prepare the science now.”

His work remains grounded in one goal: predictability. A well-built product does not call attention to itself. It works every time. “If we do our job right,” he says, “no one should ever notice. It just works.”